NCT03037385 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 13
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 12
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 528
- group Id
- BG010
- value
- 590
- units
- Participants
- groups
- description
- Participants received pralsetinib 30 milligrams (mg) orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG000
- title
- Phase I: Pralsetinib 30 mg
- description
- Participants received pralsetinib 60 mg orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG001
- title
- Phase I: Pralsetinib 60 mg
- description
- Participants received pralsetinib 100 mg orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG002
- title
- Phase I: Pralsetinib 100 mg
- description
- Participants received pralsetinib 200 mg orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG003
- title
- Phase I: Pralsetinib 200 mg
- description
- Participants received pralsetinib 300 mg, orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG004
- title
- Phase I: Pralsetinib 300 mg
- description
- Participants received pralsetinib 400 mg orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG005
- title
- Phase I: Pralsetinib 400 mg
- description
- Participants received pralsetinib 600 mg orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG006
- title
- Phase I: Pralsetinib 600 mg
- description
- Participants received pralsetinib 100 mg, orally, twice a day (BID) until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG007
- title
- Phase I: Pralsetinib 100/100 mg
- description
- Participants received pralsetinib 200 mg in the morning and then 100 mg in the evening orally until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG008
- title
- Phase I: Pralsetinib 200/100 mg
- description
- Participants with advanced NSCLC, advanced non-resectable TC and other advanced non-resectable solid tumors with various rearranged during transfection (RET)-alterations were enrolled in this arm to receive pralsetinib, 400 mg, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG009
- title
- Phase II: Pralsetinib 400 mg
- description
- Total of all reporting groups
- id
- BG010
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.2
- value
- 54.5
- group Id
- BG001
- spread
- 18.0
- value
- 49.5
- group Id
- BG002
- spread
- 13.2
- value
- 51.2
- group Id
- BG003
- spread
- 13.6
- value
- 53.8
- group Id
- BG004
- spread
- 11.0
- value
- 60.6
- group Id
- BG005
- spread
- 17.8
- value
- 49.2
- group Id
- BG006
- spread
- 9.1
- value
- 59.5
- group Id
- BG007
- spread
- 11.09
- value
- 63.0
- group Id
- BG008
- spread
- 18.25
- value
- 61.8
- group Id
- BG009
- spread
- 12.6
- value
- 57.7
- group Id
- BG010
- spread
- 12.8
- value
- 57.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 257
- group Id
- BG010
- value
- 283
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 271
- group Id
- BG010
- value
- 307
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 19
- group Id
- BG010
- value
- 28
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 12
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 465
- group Id
- BG010
- value
- 516
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 44
- group Id
- BG010
- value
- 46
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 203
- group Id
- BG010
- value
- 209
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- group Id
- BG010
- value
- 2
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 4
- group Id
- BG010
- value
- 6
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 284
- group Id
- BG010
- value
- 331
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 3
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 32
- group Id
- BG010
- value
- 39
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Safety population included all participants who had received at least 1 dose of the study drug regardless of the starting dose levels.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 13
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 12
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 528
- group Id
- BG010
- value
- 590
- units
- Participants
- groups
- description
- Participants received pralsetinib 30 milligrams (mg) orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG000
- title
- Phase I: Pralsetinib 30 mg
- description
- Participants received pralsetinib 60 mg orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG001
- title
- Phase I: Pralsetinib 60 mg
- description
- Participants received pralsetinib 100 mg orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG002
- title
- Phase I: Pralsetinib 100 mg
- description
- Participants received pralsetinib 200 mg orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG003
- title
- Phase I: Pralsetinib 200 mg
- description
- Participants received pralsetinib 300 mg, orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG004
- title
- Phase I: Pralsetinib 300 mg
- description
- Participants received pralsetinib 400 mg orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG005
- title
- Phase I: Pralsetinib 400 mg
- description
- Participants received pralsetinib 600 mg orally, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG006
- title
- Phase I: Pralsetinib 600 mg
- description
- Participants received pralsetinib 100 mg, orally, twice a day (BID) until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG007
- title
- Phase I: Pralsetinib 100/100 mg
- description
- Participants received pralsetinib 200 mg in the morning and then 100 mg in the evening orally until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG008
- title
- Phase I: Pralsetinib 200/100 mg
- description
- Participants with advanced NSCLC, advanced non-resectable TC and other advanced non-resectable solid tumors with various rearranged during transfection (RET)-alterations were enrolled in this arm to receive pralsetinib, 400 mg, QD until discontinuation due to toxicity, disease progression, or other reasons.
- id
- BG009
- title
- Phase II: Pralsetinib 400 mg
- description
- Total of all reporting groups
- id
- BG010
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.2
- value
- 54.5
- group Id
- BG001
- spread
- 18.0
- value
- 49.5
- group Id
- BG002
- spread
- 13.2
- value
- 51.2
- group Id
- BG003
- spread
- 13.6
- value
- 53.8
- group Id
- BG004
- spread
- 11.0
- value
- 60.6
- group Id
- BG005
- spread
- 17.8
- value
- 49.2
- group Id
- BG006
- spread
- 9.1
- value
- 59.5
- group Id
- BG007
- spread
- 11.09
- value
- 63.0
- group Id
- BG008
- spread
- 18.25
- value
- 61.8
- group Id
- BG009
- spread
- 12.6
- value
- 57.7
- group Id
- BG010
- spread
- 12.8
- value
- 57.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 257
- group Id
- BG010
- value
- 283
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 271
- group Id
- BG010
- value
- 307
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 19
- group Id
- BG010
- value
- 28
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 12
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 465
- group Id
- BG010
- value
- 516
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 44
- group Id
- BG010
- value
- 46
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 203
- group Id
- BG010
- value
- 209
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- group Id
- BG010
- value
- 2
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 4
- group Id
- BG010
- value
- 6
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 284
- group Id
- BG010
- value
- 331
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 3
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 32
- group Id
- BG010
- value
- 39
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Safety population included all participants who had received at least 1 dose of the study drug regardless of the starting dose levels.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle